New Study: Medicare’s Price Controls Are Fueling America’s Growing Doctor Shortage
The Pacific Research Institute’s Center for Medical Economics and Innovation today released a new issue brief warning that continued federal underpayment of doctors is fueling a looming healthcare crisis by accelerating the nation’s physician shortage and undermining access to care. Written by PRI senior fellow in business and economics and CMEI director Dr. Wayne Winegarden, the brief (titled “It’s Time for Medicare to Stop Shortchanging Physicians”) finds that Medicare reimbursement rates are well below market ...
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live webinar with Pipes on Wednesday, February 26 at 11 AM Pacific time, discussing her new book in conversation with PRI’s Dr. Wayne Winegarden. In ...
How do price controls damage innovation?
What role do intellectual property laws play in encouraging innovation? They are absolutely essential. IP protections like patents reward those who succeed in creating new medicines and ushering them through the regulatory approval process. They do this by guaranteeing that the IP rights holder behind a new drug will have a period of exclusive sales. There are several kinds of IP protections that apply to drugs in the United States. Patents, of course, are enshrined ...
Trending Topics
Single Payer
Medical Debt
Drug Prices
Studies
Podcasts
Sally Pipes – On the Health Care Debate in Washington
December 1, 2025
Sally Pipes – The World’s Medicine Chest
March 3, 2025
Wayne Winegarden – The Impact of Covid-19 Restrictions
October 2, 2023
Bill Smith – Rationing Medicine
May 23, 2023
Blogs
How do price controls damage innovation?
Sally C. Pipes
December 17, 2025
Learn How Drug Price Controls Hurt Patients
Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs
Wayne Winegarden
October 8, 2025
Read part 3 of a series on drug pricing
Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition
Wayne Winegarden
July 30, 2025
Commentary
Democrats Can’t End Private-Sector Drug Innovation Fast Enough
Sally C. Pipes
December 15, 2025
Why reforming PBMs is the key to lowering drug costs
Wayne H Winegarden
December 12, 2025











